Related Experiment Video
Updated: Jan 9, 2026
09:33
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.6K
MicroRNA Profiling Identifies Diagnostic and Prognostic Markers in Pediatric Sarcoma
Terrie G Flatt1, Leonid M Yermakov2, Shreeram Akilesh2
1Department of Pediatrics, Division of Hematology & Oncology, Children's Mercy Hospital, University of Missouri, Kansas City, MO 64110, USA.
Cancers
|December 11, 2025
Summary
Distinct microRNA (miRNA) profiles can differentiate pediatric sarcomas like rhabdomyosarcoma (RMS), Ewing's sarcoma (EWS), and osteosarcoma (OS). These miRNA signatures offer insights into tumor biology and prognosis.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- MicroRNAs (miRNAs) are key gene regulators in cancer.
- Their specific roles in pediatric sarcomas are not well understood.
Purpose of the Study:
- To investigate microRNA expression profiles in pediatric sarcomas.
- To determine if miRNA signatures can differentiate sarcoma types and subtypes.
Main Methods:
- Analyzed miRNA expression in 108 pediatric tumors (osteosarcoma, Ewing's sarcoma, rhabdomyosarcoma) using NanoString nCounter.
- Validated candidate miRNAs using in situ hybridization (miRNA-ISH) on an independent cohort.
Main Results:
- Identified distinct miRNA signatures for RMS, EWS, and OS.
- miR-206 strongly associated with RMS; miR-9-5p with EWS; miR-140-5p with OS.
- miRNA profiles differentiated RMS subtypes and correlated with patient outcomes.
Conclusions:
- Specific miRNA profiles can distinguish pediatric sarcoma types and subtypes.
- These findings provide insights into tumor biology and prognosis.
- Potential for diagnostic applications of miRNA profiling in pediatric sarcomas.
Keywords:
Ewing’s sarcomaNanoString nCountermicroRNAmicroRNA in situ hybridizationosteosarcomarhabdomyosarcoma
